文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症易感性与严重度的关键遗传决定因素:一项系统性多维分析

KEY GENETIC DETERMINANTS OF SEPSIS SUSCEPTIBILITY AND SEVERITY: A SYSTEMATIC MULTIDIMENSIONAL ANALYSIS.
PubMed 文献 · Shock · 2025-01-01
一句话结论基于UK Biobank的孟德尔随机化分析发现PSMA4是脓毒症易感性和严重度最稳健的因果基因,并可能成为治疗靶点。

本研究利用UK Biobank的全基因组关联研究数据,对72个候选基因进行两样本孟德尔随机化分析,并结合蛋白-蛋白互作网络、热图可视化、贝叶斯共定位、区域关联分析和转录组测序。结果发现PSMA4基因在所有脓毒症表型中均为最稳健的因果基因:脓毒症β=0.23(P=4.07×10-36)、重症监护脓毒症β=0.22(P=3.49×10-4)、重症监护脓毒症28天死亡β=0.43(P=5.94×10-19)。共定位证实PSMA4表达与脓毒症风险共享因果变异(PP.H4.abf=96.5%),转录组数据显示PSMA4在脓毒症(P=0.003)和脓毒症休克(P<0.001)患者中表达显著升高。作者认为PSMA4是脓毒症易感性和疾病严重度的关键遗传风险因素,并可能作为治疗靶点。

要点

  • 在UK Biobank数据的两样本孟德尔随机化分析中,PSMA4是全部脓毒症表型中最稳健的因果基因。
  • PSMA4与脓毒症的因果关联β=0.23(P=4.07×10-36),与重症监护脓毒症β=0.22(P=3.49×10-4),与重症监护脓毒症28天死亡β=0.43(P=5.94×10-19)。
  • 贝叶斯共定位显示PSMA4表达与脓毒症风险共享因果变异,PP.H4.abf=96.5%。
  • 转录组数据中PSMA4表达在脓毒症患者(P=0.003)和脓毒症休克患者(P<0.001)中显著升高。
  • 作者认为PSMA4是脓毒症易感性和严重度的关键遗传风险因素,并可能作为治疗靶点。

研究设计与关键结果

  • 研究类型:利用UK Biobank全基因组关联研究数据的两样本孟德尔随机化分析,对72个候选基因进行系统研究。
  • 补充方法包括蛋白-蛋白互作网络映射、热图可视化、贝叶斯共定位、区域关联分析和转录组测序。
  • PSMA4与脓毒症的因果关联:β=0.23(P=4.07×10-36)。
  • PSMA4与重症监护脓毒症的因果关联:β=0.22(P=3.49×10-4)。
  • PSMA4与重症监护脓毒症28天死亡的因果关联:β=0.43(P=5.94×10-19)。
  • 共定位分析证实PSMA4表达与脓毒症风险共享因果变异,PP.H4.abf=96.5%。
  • 转录组数据显示PSMA4表达在脓毒症患者中显著升高(P=0.003),在脓毒症休克患者中显著升高(P<0.001)。

证据类型、等级与局限

  • 证据类型:基于UK Biobank全基因组关联研究数据的孟德尔随机化分析,结合蛋白-蛋白互作网络、贝叶斯共定位、区域关联分析和转录组测序。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为PSMA4是脓毒症易感性和疾病严重度的关键遗传风险因素,并可能作为治疗靶点,为脓毒症管理提供潜在方向。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Sepsis, a life-threatening condition driven by dysregulated immune responses, imposes a substantial global health burden. Despite advancements, its complex pathophysiology and urgent need for timely intervention underscore the necessity to identify novel genetic risk factors. This study aimed to systematically investigate causal genetic determinants of sepsis and its severe subtypes. Methods: Leveraging genome-wide association study data from the UK Biobank, two-sample Mendelian randomization analysis was performed on 72 candidate genes. Complementary methods included protein-protein interaction network mapping, heatmap visualization, Bayesian colocalization, regional association analysis, and transcriptomic sequencing. Results: A series of genes was identified to be causally associated with severe sepsis subtypes. The PSMA4 gene emerged as the most robust causal gene across all sepsis phenotypes (sepsis: β = 0.23, P = 4.07 × 10-36; sepsis in critical care: β = 0.22, P = 3.49 × 10-4; sepsis with 28-day death in critical care: β = 0.43, P = 5.94 × 10-19). Colocalization confirmed a shared causal variant between PSMA4 expression and sepsis risk (PP.H4.abf = 96.5%). In the transcriptomic data, we found that the expression of PSMA4 was significantly elevated in sepsis and septic shock patients (P = 0.003 for sepsis patients and P < 0.001 for septic shock patients, respectively). Conclusion: By employing a comprehensive multidimensional approach, we identified key genetic contributors to sepsis, with PSMA4 emerging as the most significant genetic risk factor underlying both susceptibility and disease severity. These findings highlighted PSMA4 as a therapeutic target, offering the potential for sepsis management.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Weng J, Lin J, Ye Y, et al. KEY GENETIC DETERMINANTS OF SEPSIS SUSCEPTIBILITY AND SEVERITY: A SYSTEMATIC MULTIDIMENSIONAL ANALYSIS. Shock. 2025. PMID: 40952416. doi:10.1097/SHK.0000000000002643

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。